Estrella Immunopharma enters employment agreement with CEO Cheng Liu; base salary $250,000

Estrella Immunopharma, Inc.

Base salary of $250,000 per year, plus annual cash bonus based on performance metrics set by Compensation Committee.
Severance: 6 months base salary for termination without cause or resignation for good reason; 12 months plus equity acceleration if tied to change in control.
Agreement includes non-disclosure and confidentiality covenants; effective November 1, 2024, at-will employment.
CEO retains ability to hold outside directorships and positions, subject to Board review.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.